David Mason
Investor Relations
Replay available
HLS Therapeutics Inc. (HLS) Q1 2026 Earnings Call
HLS Therapeutics Inc. (TSX: HLS) Q1 2026 earnings conference call, held 2026-05-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Craig Million
Chief Executive Officer
Brian Walsh
Chief Commercial Officer
John Hanna
Chief Financial Officer
Michael Freeman
Analyst, Raymond James
Unknown Speaker
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Hls Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.031 Thank 00:00:03.614 -- 00:00:05.614 you. 00:01:59.523 -- 00:02:02.264 . . . . . 00:02:41.423 -- 00:02:43.423 Thank 00:02:46.830 -- 00:02:48.830 you. 00:03:15.882 -- 00:03:20.686 Good morning and welcome to the Q1 Fiscal 2026 00:03:20.686 -- 00:03:25.830 Financial Results Conference Call for the HLS Therapeutics. 00:03:25.830 -- 00:03:30.755 At this point, I would like to turn the call over to David Mason, Investor Relations, 00:03:30.755 -- 00:03:34.336 for the introductory remarks. 00:03:34.858 -- 00:03:38.821 Good morning, everyone, and thank you for joining us today. 00:03:38.821 -- 00:03:44.406 With me on the call is Craig Million, Chief Executive Officer, John Hanna, 00:03:44.406 -- 00:03:49.183 Chief Financial Officer, and Brian Walsh, Chief Commercial Officer. 00:03:49.183 -- 00:03:53.988 Earlier this morning, we issued a news release announcing our financial results for the 00:03:53.988 -- 00:03:58.811 three months ended March 31st, 2026. This 00:03:58.814 -- 00:04:03.899 news release, along with our MDMA and financial statements, is available on our 00:04:03.899 -- 00:04:06.922 website and on CDAR+. 00:04:06.922 -- 00:04:12.548 Please note that slides accompanying today's call can be viewed by the webcast, 00:04:12.548 -- 00:04:17.476 a link to which is available in our earnings press release and on our website on the 00:04:17.476 -- 00:04:19.699 events page. 00:04:19.699 -- 00:04:24.286 Certain matters discussed in today's conference call or answers that may be given to 00:04:24.286 -- 00:04:28.213 questions could constitute forward-looking statements. 00:04:28.213 -- 00:04:32.299 Actual results could differ materially from those anticipated. 00:04:32.299 -- 00:04:36.866 Risk factors that could affect results are detailed ...